upcarta
  • Sign In
  • Sign Up
  • Explore
  • Search
Mentions
Manni Mohyuddin @ManniMD1 ยท Feb 10, 2023
  • From Twitter

Dr Costa- loved this thread. The power calculations reflected a much higher performance of the control arm (9 months) compared to what we saw (4 months). Why do you think that was the case?

Tweet Jan 6, 2023
Now that horse is out of the barn... a few important points about KARMMA-3 #mmsm @paurotero @NBahlis @MyelomaTeacher #myeloma 1/X - First randomized phase 3 trial to show clinical benefit for Car-T cell therapy in MM. That is HUGE. twitter.com/Rahul
by Luciano J Costa
Post Add to Collection Mark as Completed
Recommended by 1 person
1 mention
Share on Twitter Repost
  • upcarta ©2025
  • Home
  • About
  • Terms
  • Privacy
  • Cookies
  • @upcarta